Please login to the form below

Not currently logged in
Email:
Password:

Chiltern promotes Stuart McGuire and Jim Szymeczek

CRO fills two senior roles

Chiltern Stuart McGuireContract research organisation (CRO) Chiltern has promoted Stuart McGuire and Jim Szmeczek to senior roles.

McGuire (pictured right) is based in Slough, UK and becomes vice president, global business development and will also join the firm's group executive board.

He has been with the company for more than 12 years and during that time he led Chiltern's global business development team, a function the firm said has seen significant growth.

Chiltern has also promoted Jim Szymeczek, who becomes vice president, global information technology and systems.

Szymeczek, who is based in Wilmington, US, has more than 22 years of data and analytical science experience and joined Chiltern in 2006.

In his new role, he will oversee and provide strategy for the global IT team in its three structural areas: IT operations, clinical systems and commercial systems. 

Szymeczek will also be involved with technology related partnerships and sponsor activities.

Jim Esinhart, Chiltern's CEO, said of McGuire and Szmeczek: “Their leadership and depth of experience strengthens Chiltern's mission of delivering high quality, innovative and responsive services to meet our clients' needs.”

27th March 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics